Summary
M2 EQUITYBITES-August 29, 2011-Bristol-Myers Squibb and Pfizer reports main results in Phase 3 ARISTOTLR trial for ELIQUIS
(C)1994-2011 M2 COMMUNICATIONS http://www.m2.comSee the full content of this document
Extract
Aristotlr Trial for Eliquis
Biopharmaceutical company Bristol-Myers Squibb Company (NYSE:BMY) and healt...
See the full content of this document
Sponsored links
